Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Immune changes and specific genes contribute to male hair loss.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

ILC1 cells contribute to hair loss in alopecia areata.

New drug delivery systems improve treatment effectiveness and patient experience.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Rodent models helped understand psoriasis but none perfectly replicated the disease.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

Finasteride can cause a unique skin reaction on the penile shaft.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.